Pyridoindole derivatives
    1.
    发明授权
    Pyridoindole derivatives 失效
    吡啶并吲哚衍生物

    公开(公告)号:US4336256A

    公开(公告)日:1982-06-22

    申请号:US184070

    申请日:1980-09-04

    CPC分类号: C07D471/04 Y10S514/923

    摘要: Pyridoindole derivatives of formula ##STR1## n=0 or 1; R.sub.1 =H, Hal, alk, alk--O--, CF.sub.3 ; R.sub.2 =--COOalk; --CONHR.sub.5 (R.sub.5 =H or various substituents); R.sub.3 =H, alk, --COOalk; R.sub.4 =H, Ac, alk, --CONHR.sub.6 (R.sub.6 =H or various substituents), and acid addition salts, except certain known compounds, are useful in treating anoxia and depression and in psychotropic therapy. They are prepared from tryptamine or a derivative thereof by reaction thereof with a pyruvic ester or 3-ethoxycarbonyl-1,2-dioxo-1-ethoxypropane to form compounds in which R.sub.4 is H and R.sub.2 is --COOalk. These compounds are reacted with amines, isocyanates or usual N-acylating or N-alkylating reagents to prepare the other compounds.

    摘要翻译: 式(I)的吡啶并吲哚衍生物n = 0或1; R1 = H,Hal,alk,alk-O-,CF3; R2 = -COOalk; -CONHR5(R5 = H或各种取代基); R3 = H,alk,-COOalk; R4 = H,Ac,alk,-CONHR6(R6 = H或各种取代基),除了某些已知化合物之外,酸加成盐可用于治疗缺氧和抑郁症以及精神药物治疗。 它们由色胺或其衍生物通过与丙酮酸酯或3-乙氧基羰基-1,2-二氧代-1-乙氧基丙烷的反应制备,以形成其中R 4为H且R 2为-COOalk的化合物。 这些化合物与胺,异氰酸酯或通常的N-酰化或N-烷基化试剂反应以制备其它化合物。